In 2012 Brahmer et al. [52] treated 207 patients with advanced solid tumors, including 17 women with ovarian cancer, with BMS-936559, a fully-human IgG4 antibody targeting PD-L1. The gene discussed is CD274; the disease is ovarian carcinoma.